Solutions for a lifetime
Enabling ETR for the First Time

Enabling ETR
for the First Time

The Xeltis bioabsorbable cardiovascular devices are porous matrices designed to work as valves or vessels and to allow ETR as the body’s natural healing process pervades them with new functioning tissue. Read more here.

Latest News

Latest News

Xeltis extends series B financing to €30M, signing off transformational year

Read more here.


Xeltis AG – Zürich

Mühlebachstrasse 26
CH-8008 Zurich, Switzerland

View Map